Clinical trials in Koper

2 clinical trials in Koper, Slovenia. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SloveniaKlinicnaPreskusanja.si

Koper at a glance

clinical trials

Recruiting now0
Not yet recruiting0
Paediatric trials0
Research sites0

Quick filters

2 trials in Koper

Open in trial search

Type 2 diabetes mellitus

Not recruiting

A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

Registered drug

A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

Registered drug

Slovenia

Participants:18–64 years · 65+ years
Substances:Cagrilintide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Hyperlipidaemia

Not recruiting

Study on Lowering Cholesterol with Rosuvastatin or Rosuvastatin/Ezetimibe in Patients at High or Very High Risk of Cardiovascular Disease with High Cholesterol

Registered drugNo placebo

Study on Lowering Cholesterol with Rosuvastatin or Rosuvastatin/Ezetimibe in Patients at High or Very High Risk of Cardiovascular Disease with High Cholesterol

Registered drugNo placebo

Slovenia

Participants:18–64 years · 65+ years
Substances:Ezetimibe
Sponsor:KRKA tovarna zdravil d.d. Novo mesto

Contact Research Centre

Other cities in Slovenia

The busiest research cities in the country

All 18 cities in Slovenia

Clinical research in Koper

What the registry says about research in the country

01 Cardiovascular Research

Clinical research focusing on treating patients with hyperlipidaemia and evaluating cardiovascular disease risk management strategies. The trials investigate the effectiveness of different therapeutic approaches in controlling cholesterol levels.

Lipid Management
Cardiovascular Risk Reduction
Cholesterol Control

These studies aim to evaluate treatment efficacy in achieving specific LDL-C reduction targets for patients at high and very high cardiovascular risk, contributing to improved cardiovascular health outcomes.

Back to Slovenia All countries